MARKER THERAPEUTICS, INC. (MRKR) Operating income 2016–2025
MARKER THERAPEUTICS, INC. (MRKR) annual operating income history from SEC filings — each fiscal year as reported.
-$12.9MFY2025 · since FY2016: -$8.5M → -$12.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.9M | -15.9% |
| FY2024 | -$11.1M | +23.7% |
| FY2023 | -$14.6M | +26.3% |
| FY2022 | -$19.8M | +49.9% |
| FY2021 | -$39.5M | -36.7% |
| FY2020 | -$28.9M | -28.2% |
| FY2019 | -$22.5M | +84.8% |
| FY2018 | -$148.2M | -1190.7% |
| FY2017 | -$11.5M | -35.2% |
| FY2016 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →